Company Filing History:
Years Active: 1999-2000
Title: **Masahiro Yamazaki: Innovator in Photostable Aqueous Solutions**
Introduction
Masahiro Yamazaki is a distinguished inventor based in Fukui, Japan. He has made significant contributions to the field of pharmaceuticals with his innovative solutions, particularly focusing on photostability in aqueous formulations. With two patents to his name, Yamazaki's work is recognized for its impact on drug formulation technology.
Latest Patents
Yamazaki's latest patent, titled "Photostable aqueous solution comprising benzyl alcohol derivatives," outlines a novel aqueous solution that includes optically active (-)-(R)-α-((tert-butylamino)methyl)-2-chloro-4-hydroxybenzyl alcohol and pharmacologically acceptable salts of the same. The formulation is designed to enhance photostability and includes various photostabilizers such as saccharides, sugar alcohols, or polyalcohols. The patent specifies composition ratios, where the content of the active compound ranges from 0.01 to 10% (w/v), and the photostabilizer content is between 1 to 50% (w/v), ensuring effective stabilization in pharmaceutical applications.
Career Highlights
Masahiro Yamazaki currently works at Hokuriku Seiyaku Co., Ltd., a company renowned for its commitment to developing high-quality pharmaceutical products. His research focuses on improving existing formulations and creating innovative solutions that address the stability of active ingredients in various environments.
Collaborations
Throughout his career, Yamazaki has collaborated with notable coworkers, including Yasuo Ito and Hideo Kato. These collaborations have fostered a creative and productive environment that enhances the development of impactful pharmaceutical innovations.
Conclusion
As an inventor, Masahiro Yamazaki exemplifies the spirit of innovation in the pharmaceutical industry. His contributions, particularly in the realm of photostable aqueous solutions, are valuable in advancing drug formulation techniques. With ongoing research and collaboration, Yamazaki is poised to continue his important work in enhancing pharmaceutical products and their effectiveness.